Showing posts with label MicroVention. Show all posts
Showing posts with label MicroVention. Show all posts

Terumo Vascular

>> Sunday, January 3, 2010


Terumo’s main products in the neuro endovascular field revolve around a family of gold tipped guide wires (Glidewire).
In March 2006 the company acquired MicroVention with its complete neuroendovascular product line.

Read more...

Terumo Vascular


Terumo’s main products in the neuro endovascular field revolve around a family of gold tipped guide wires (Glidewire).
In March 2006 the company acquired MicroVention with its complete neuroendovascular product line.

Read more...

MicroVention

>> Saturday, January 2, 2010

MicroVention, founded in 1997 in Tustin California, develops a range of minimally invasive catheter-based products to treat cerebral aneurysms and ischemic stroke.

 MicroVention’s main products are MicroPlex Coil System and the HydroCoil Embolic System, its next-generation endovascular coil system which incorporates proprietary hydrogel technology.

MicroVention is also developing an aneurysm stent in-house as well as seeking possible acquisition of such device for another company.

In March 2006 Microvention was acquired by Terumo corporation. Microvention 2009 sale of its neuroendovascular product line was estimated at US$20 million.  Combined MicroVention / Terumo neuroendovascular sales are estimated at US$40 million.

Read more...

MicroVention

MicroVention, founded in 1997 in Tustin California, develops a range of minimally invasive catheter-based products to treat cerebral aneurysms and ischemic stroke.

 MicroVention’s main products are MicroPlex Coil System and the HydroCoil Embolic System, its next-generation endovascular coil system which incorporates proprietary hydrogel technology.

MicroVention is also developing an aneurysm stent in-house as well as seeking possible acquisition of such device for another company.

In March 2006 Microvention was acquired by Terumo corporation. Microvention 2009 sale of its neuroendovascular product line was estimated at US$20 million.  Combined MicroVention / Terumo neuroendovascular sales are estimated at US$40 million.

Read more...

  © eReports

Back to TOP